Evidence map›Paper›PMID 40428217›Full record

ReviewDiagnostics (Basel, Switzerland)2025

Detection Rates of PSMA-PET Radiopharmaceuticals in Recurrent Prostate Cancer: A Systematic Review.

Soroush Rais-Bahrami, Phillip Davis, Albert Chau, Samuel J Galgano, Brian F Chapin, David M Schuster, Catriona M Turnbull

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. An intra-patient contemporaneous comparison ofEuropean journal of nuclear medicine and molecular imaging · 2026
    Trial
  3. Review
  4. Value of a repeatEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Soroush Rais-BahramiDepartment of Urology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0001-9466-9925
Phillip DavisBlue Earth Diagnostics Inc., Needham, MA 02494, USA.
Albert ChauBlue Earth Diagnostics Ltd., Oxford OX4 4GA, UK.
Samuel J GalganoDepartment of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Brian F ChapinDepartment of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
David M SchusterDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0003-3077-742X
Catriona M TurnbullBlue Earth Diagnostics Ltd., Oxford OX4 4GA, UK.

Funding

Blue Earth Diagnostics (United Kingdom) NA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biochemical recurrencepositron emission tomographyprostate cancer imagingprostate specific membrane antigen

Identifiers

PMID40428217
PMCPMC12110065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.